A case report of preferential effectiveness of clonazepam over lorazepam in the management of a case of alprazolam withdrawal
Benzodiazepines (BZDs) remain the mainstay in the management of withdrawal arising out of BZD use disorders. The choice of detoxifying agent is determined by the duration of action and also by the metabolic properties of the drug. Very rarely, we consider the chemical properties of the drug that we...
Main Authors: | Vrinda Saxena, Robin Victor, Arghya Pal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Geriatric Mental Health |
Subjects: | |
Online Access: | http://www.jgmh.org/article.asp?issn=2348-9995;year=2018;volume=5;issue=2;spage=165;epage=166;aulast=Saxena |
Similar Items
-
Oral clonazepam versus lorazepam in the treatment of methamphetamine-poisoned children: a pilot clinical trial
by: Fariba Farnaghi, et al.
Published: (2020-12-01) -
A Randomized Comparison of Lorazepam and Chlordiazepoxide in Patients With Uncomplicated Alcohol withdrawal
by: Vishnu Gade, et al.
Published: (2017-01-01) -
Effect of benzodiazepines on thyroglobulin, anti-thyroglobulin, anti-thyroid peroxidase, and thyroid stimulating hormone in rat
by: Mohammad-Hasan Khadem-Ansari, et al.
Published: (2014-01-01) -
Alprazolam addiction: The case study
by: O. Pityk, et al.
Published: (2021-04-01) -
Lorazepam: A Weapon of Offence
by: Satinder Pal Singh, et al.
Published: (2015-03-01)